Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant:Infection & Immunity-PHAC-CAID/Hep C Res Init/Biomed/clin stream

Université de Montréal

$100,000.00

Identification of new regulators of the innate antiviral response using a genome-scale lentiviral-based RNAi screen.

EF 2009-10

Résumé
The immediate-early phase of the host innate response to viral infection is initiated through pathogen recognition and expression of early protective genes such as type I interferon (IFN). Here, we performed a genome-scale RNA interference screen to identify positive and negative regulators of the innate response to virus infection. Our approach will identify new gene products either restricting or facilitating the replication of RNA viruses such as HCV, HIV and newly identified virulent strains of influenza. The pharmacological modulation of regulators could lead to novel human therapeutic targets and immune-based therapies for treating viral infection.
Programme
Catalyst Grant:Infection & Immunity-PHAC-CAID/Hep C Res Init/Biomed/clin stream
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
198508
Name
Lamarre Daniel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Infection and Immunity
Projecttitle
Identification of new regulators of the innate antiviral response using a genome-scale lentiviral-based RNAi screen.
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant:Infection & Immunity-PHAC-CAID/Hep C Res Init/Biomed/clin stream
Keyworddelim
Genome-Wide Screen; Hepatitis C Virus; Innate Immunity; Rnai
Abstract
The immediate-early phase of the host innate response to viral infection is initiated through pathogen recognition and expression of early protective genes such as type I interferon (IFN). Here, we performed a genome-scale RNA interference screen to identify positive and negative regulators of the innate response to virus infection. Our approach will identify new gene products either restricting or facilitating the replication of RNA viruses such as HCV, HIV and newly identified virulent strains of influenza. The pharmacological modulation of regulators could lead to novel human therapeutic targets and immune-based therapies for treating viral infection.
Competitiondate
200909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lamarre, Daniel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~